Company news

Geron Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights

May 9, 2021

Geron to Announce First Quarter 2021 Financial Results on May 10, 2021

May 2, 2021

Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis

April 12, 2021

Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

March 10, 2021

Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

February 28, 2021

Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis

December 10, 2020

Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS

December 9, 2020

Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting

December 6, 2020

Geron to Present at the Stifel Virtual Healthcare Conference

November 9, 2020

Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events

November 4, 2020

Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting

November 3, 2020

Geron to Announce Third Quarter Financial Results on November 5, 2020

October 28, 2020

Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology

October 27, 2020

Geron Secures Loan Facility for Up to $75 Million

September 30, 2020

Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events

August 5, 2020

Geron to Present at the BTIG Virtual Biotechnology Conference

August 3, 2020

Geron to Announce Second Quarter Financial Results on August 6, 2020

July 29, 2020

Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic Syndromes

June 30, 2020

Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress

June 11, 2020

Geron Corporation Reports First Quarter 2020 Financial Results

May 27, 2020

Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates

May 20, 2020

Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress

May 13, 2020

Geron Provides COVID-19 Related Business Update

April 1, 2020

Geron Corporation Reports Fourth Quarter and Full Year 2019 Financial Results and 2020 Milestones

March 11, 2020

Geron to Announce Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

March 4, 2020

Geron Announces 2019 Accomplishments and Key Development Priorities for 2020

January 12, 2020

Geron Announces Appointment of New Executive to Focus on Corporate Strategy

December 2, 2019

Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events

November 5, 2019

Geron to Announce Third Quarter Financial Results on November 6, 2019

October 30, 2019

Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

October 9, 2019

Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis

September 29, 2019

Geron Expands Senior Leadership of Its Development Team

April 17, 2019

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 32 decks. Every deck is listed under its year.